Miromatrix Medical Inc.
MIRODelisted Dec 13, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001527096
Miromatrix Medical Inc. was delisted on Dec 13, 2023; its insiders filed their last Form 4 on Dec 13, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $8.78M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Miromatrix Medical Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 22 | 21 | −1 |
| Shares | 3.08M | 3.18M | +93.5K (+3.0%) |
| Value | $14.5M | $12.6M | −$1.88M (−13.0%) |
New holders (6)
Institutions that held Miromatrix Medical Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Stillwater Investment Management, LLC | 90,146 | $357.0K | 0.09% |
| Commonwealth Equity Services, LLC | 26,669 | $105.0K | 0.00% |
| State Street Corp | 23,417 | $93.0K | 0.00% |
| Ulland Investment Advisors, LLC | 12,000 | $48.0K | 0.04% |
| Morgan Stanley | 1,507 | $6.00K | 0.00% |
| Advisor Group Holdings, Inc. | 200 | $1.00K | 0.00% |
Sold out (7)
Institutions that held Miromatrix Medical Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Polar Asset Management Partners Inc. | 250,451 | $1.18M |
| Friess Associates LLC | 246,323 | $1.16M |
| Granite Point Capital Management, L.P. | 177,642 | $833.0K |
| Renaissance Technologies LLC | 15,821 | $74.0K |
| Citadel Advisors LLC | 16,013 | $74.0K |
| Jane Street Group, LLC | 12,212 | $57.0K |
| Sweet Financial Partners, LLC | 10,000 | $47.0K |